Effects of High-Frequency Oscillatory Ventilation With Volume Guarantee During Surfactant Treatment in Extremely Low Gestational Age Newborns With Respiratory Distress Syndrome: An Observational Study.

OBJECTIVE

To evaluate the effect of volume guarantee (VG) combined with high-frequency oscillatory ventilation (HFOV) on respiratory and other physiological parameters immediately after lung recruitment and surfactant administration in HFOV elective ventilated extremely low gestational age newborns (ELGAN) with respiratory distress syndrome (RDS).

DESIGN

Observational study.

SETTING

Tertiary neonatal intensive care unit.

PATIENTS

Twenty-two ELGANs of 25.5 ± 1.1 weeks of gestational age requiring invasive mechanical ventilation and surfactant administration for RDS during the first 6 h of life.

INTERVENTIONS

All infants intubated in delivery room, were managed with elective HFOV and received surfactant after a lung recruitment manoeuver. Eleven infants received HFOV + VG and were compared with a control group of 11 infants receiving HFOV alone. HFOV was delivered in both groups by Dräger Babylog VN500 ventilator (Dräger, Lubeck, Germany).

MAIN OUTCOME MEASURES

Variations and fluctuations of delivered high-frequency tidal volume (VT), fluctuation of pressure amplitude (ΔP) and partial pressure of CO (pCO) levels after recruitment manoeuver and immediately after surfactant administration, in HFOV + VG vs. HFOV ventilated infants.

RESULTS

There were no significant differences in the two groups at starting ventilation with or without VG. The mean applied VT per kg was 1.7 ± 0.3 ml/kg in the HFOV group and 1.7 ± 0.1 ml/kg in the HFOV + VG group. Thirty minutes after surfactant administration, HFOV group had a significant higher VT/Kg than HFOV + VG (2.1 ± 0.3 vs. 1.6 ± 0.1 ml/kg, < 0.0001) with significantly lower pCO levels (43.1 ± 3.8 vs. 46.8 ± 1.5 mmHg, = 0.01), 54.4% of patients having pCO below 45 mmHg. Measured post-surfactant ΔP values were higher in HFOV group (17 ± 3 cmHO) than in HFOV + VG group (13 ± 3 cmHO, = 0.01).

CONCLUSION

HFOV + VG maintains pCO levels within target range and reduces VT delivered variations more consistently than HFOV alone after surfactant administration.